When a myometrial invasion statement might be challenging due to the presence of adenomyosis foci [59,60], the use of NTPDase2 expression might help to overcome this limitation, since adenomyosis retains the expression while invasive (and desmoplastic) tumor areas of the sample do not. The gene discussed is ENTPD2; the disease is adenomyosis.